283 related articles for article (PubMed ID: 19370553)
1. Spironolactone versus placebo or in combination with steroids for hirsutism and/or acne.
Brown J; Farquhar C; Lee O; Toomath R; Jepson RG
Cochrane Database Syst Rev; 2009 Apr; (2):CD000194. PubMed ID: 19370553
[TBL] [Abstract][Full Text] [Related]
2. Spironolactone versus placebo or in combination with steroids for hirsutism and/or acne.
Farquhar C; Lee O; Toomath R; Jepson R
Cochrane Database Syst Rev; 2003; (4):CD000194. PubMed ID: 14583916
[TBL] [Abstract][Full Text] [Related]
3. Spironolactone versus placebo or in combination with steroids for hirsutism and/or acne.
Farquhar C; Lee O; Toomath R; Jepson R
Cochrane Database Syst Rev; 2001; (4):CD000194. PubMed ID: 11687072
[TBL] [Abstract][Full Text] [Related]
4. Spironolactone versus placebo or in combination with steroids for hirsutism and/or acne.
Lee O; Farquhar C; Toomath R; Jepson R
Cochrane Database Syst Rev; 2000; (2):CD000194. PubMed ID: 10796700
[TBL] [Abstract][Full Text] [Related]
5. Interventions for hirsutism (excluding laser and photoepilation therapy alone).
van Zuuren EJ; Fedorowicz Z; Carter B; Pandis N
Cochrane Database Syst Rev; 2015 Apr; 2015(4):CD010334. PubMed ID: 25918921
[TBL] [Abstract][Full Text] [Related]
6. Cyproterone acetate for hirsutism.
Van der Spuy ZM; le Roux PA
Cochrane Database Syst Rev; 2003; 2003(4):CD001125. PubMed ID: 14583927
[TBL] [Abstract][Full Text] [Related]
7. Statins for women with polycystic ovary syndrome not actively trying to conceive.
Xiong T; Fraison E; Kolibianaki E; Costello MF; Venetis C; Kostova EB
Cochrane Database Syst Rev; 2023 Jul; 7(7):CD008565. PubMed ID: 37462232
[TBL] [Abstract][Full Text] [Related]
8. Insulin-sensitising drugs versus the combined oral contraceptive pill for hirsutism, acne and risk of diabetes, cardiovascular disease, and endometrial cancer in polycystic ovary syndrome.
Costello M; Shrestha B; Eden J; Sjoblom P; Johnson N
Cochrane Database Syst Rev; 2007 Jan; (1):CD005552. PubMed ID: 17253562
[TBL] [Abstract][Full Text] [Related]
9. Tolerance of spironolactone.
Hughes BR; Cunliffe WJ
Br J Dermatol; 1988 May; 118(5):687-91. PubMed ID: 2969259
[TBL] [Abstract][Full Text] [Related]
10. Comparison of sequential cyproterone acetate/estrogen versus spironolactone/oral contraceptive in the treatment of hirsutism.
O'Brien RC; Cooper ME; Murray RM; Seeman E; Thomas AK; Jerums G
J Clin Endocrinol Metab; 1991 May; 72(5):1008-13. PubMed ID: 1827125
[TBL] [Abstract][Full Text] [Related]
11. Comparison of spironolactone, flutamide, and finasteride efficacy in the treatment of hirsutism: a randomized, double blind, placebo-controlled trial.
Moghetti P; Tosi F; Tosti A; Negri C; Misciali C; Perrone F; Caputo M; Muggeo M; Castello R
J Clin Endocrinol Metab; 2000 Jan; 85(1):89-94. PubMed ID: 10634370
[TBL] [Abstract][Full Text] [Related]
12. Pre-operative endometrial thinning agents before endometrial destruction for heavy menstrual bleeding.
Tan YH; Lethaby A
Cochrane Database Syst Rev; 2013 Nov; (11):CD010241. PubMed ID: 24234875
[TBL] [Abstract][Full Text] [Related]
13. Interventions for hirsutism excluding laser and photoepilation therapy alone: abridged Cochrane systematic review including GRADE assessments.
van Zuuren EJ; Fedorowicz Z
Br J Dermatol; 2016 Jul; 175(1):45-61. PubMed ID: 26892495
[TBL] [Abstract][Full Text] [Related]
14. Clinical review: Insulin sensitizers for the treatment of hirsutism: a systematic review and metaanalyses of randomized controlled trials.
Cosma M; Swiglo BA; Flynn DN; Kurtz DM; Labella ML; Mullan RJ; Elamin MB; Erwin PJ; Montori VM
J Clin Endocrinol Metab; 2008 Apr; 93(4):1135-42. PubMed ID: 18252787
[TBL] [Abstract][Full Text] [Related]
15. Spironolactone in combination with an oral contraceptive: an alternative treatment for hirsutism.
Chapman MG; Dowsett M; Dewhurst CJ; Jeffcoate SL
Br J Obstet Gynaecol; 1985 Sep; 92(9):983-5. PubMed ID: 4041402
[TBL] [Abstract][Full Text] [Related]
16. Long-term efficacy and tolerability of flutamide combined with oral contraception in moderate to severe hirsutism: a 12-month, double-blind, parallel clinical trial.
Calaf J; López E; Millet A; Alcañiz J; Fortuny A; Vidal O; Callejo J; Escobar-Jiménez F; Torres E; Espinós JJ;
J Clin Endocrinol Metab; 2007 Sep; 92(9):3446-52. PubMed ID: 17566093
[TBL] [Abstract][Full Text] [Related]
17. Oral spironolactone therapy for female patients with acne, hirsutism or androgenic alopecia.
Burke BM; Cunliffe WJ
Br J Dermatol; 1985 Jan; 112(1):124-5. PubMed ID: 3155956
[No Abstract] [Full Text] [Related]
18. Comparison of the clinical efficacy of flutamide and spironolactone plus ethinyloestradiol/cyproterone acetate in the treatment of hirsutism: a randomised controlled study.
Karakurt F; Sahin I; Güler S; Demirbas B; Culha C; Serter R; Aral Y; Bavbek N
Adv Ther; 2008 Apr; 25(4):321-8. PubMed ID: 18389188
[TBL] [Abstract][Full Text] [Related]
19. Comparison of flutamide and spironolactone in the treatment of hirsutism: a randomized controlled trial.
Cusan L; Dupont A; Gomez JL; Tremblay RR; Labrie F
Fertil Steril; 1994 Feb; 61(2):281-7. PubMed ID: 8299783
[TBL] [Abstract][Full Text] [Related]
20. Use of spironolactone in dermatology.
Rathnayake D; Sinclair R
Skinmed; 2010; 8(6):328-32; quiz 333. PubMed ID: 21413648
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
